Darren Veach

9PUBLICATIONS
43CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 14, 2026
Characterization of the D8P1C1 Anti-ADAM17 Inhibitory Monoclonal Antibody and Generation of Its Bispecific T-Cell Engager Derivative.

Nayanendu Saha, Sang Gyu Lee, Elisa de Stanchina

|Sep 09, 2024
A pan-cancer dye for solid-tumour screening, resection and wound monitoring via short-wave and near-infrared fluorescence imaging.

Benedict Edward Mc Larney, Ali Yasin Sonay, Elana Apfelbaum

|Jan 06, 2023
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response.

Claire M Storey, Mohamed Altai, Mesude Bicak

|Oct 20, 2021
Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis.

Christopher S Chandler, Meghan M Bell, Sebastian K Chung

|Jan 14, 2021
PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates.

Darren R Veach, Claire M Storey, Katharina Lückerath

|Sep 22, 2020
A Self-Assembling and Disassembling (SADA) Bispecific Antibody (BsAb) Platform for Curative Two-step Pretargeted Radioimmunotherapy.

Brian H Santich, Sarah M Cheal, Mahiuddin Ahmed

Pageof 2